Bei Yun, Shen Ze-Xu, Lin Hao-Ran, Wei Tao-Feng, Wang Yi-Hao, Su Zhi-Tao, Dai Yun-Jian, Wang Yan-Hong, Huang Ling-Ling, Zhu Tao, Hu Wei, Ye Juan, Wu Gong-Xiong, Dai Hai-Bin
Department of Pharmacy, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Department of Pharmacy, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, 313000, China.
Acta Pharmacol Sin. 2025 Mar 31. doi: 10.1038/s41401-025-01523-9.
Diabetic retinopathy (DR) is a common and specific microvascular complication of diabetes and the leading cause of blindness in working-age adults. Endothelial-mesenchymal transition (EndoMT) underlies various chronic vascular diseases, while histone deacetylase 9 (HDAC9) is involved in the pathological process of cardiovascular diseases, cerebrovascular diseases, autoimmune diseases, and breast cancer. Recent evidence has shown that HDAC9 promotes EndoMT, thereby affecting the progression of atherosclerotic disease. In this study, we investigated the critical role of HDAC9 in DR and the underlying mechanism. DR model was established in mice by injecting streptozotocin (STZ, 50 mg/kg) for 5 consecutive days. Blood glucose was monitored regularly and DR experiments were performed 12 weeks after modeling. We showed that the expression levels of HDAC9 were significantly elevated in the vitreous fluid of diabetic patients and the retinal endothelial cells of DR model mice. Knockdown of endothelial HDAC9 reduced EndoMT and alleviated DR pathology in vivo, whereas overexpression of HDAC9 exacerbated EndoMT in DR model mice. To elucidate the downstream target genes of HDAC9 implicated in DR, we conducted integrated ChIP-seq and RNA-seq analysis of the retina in STZ-induced retinopathy and established that HDAC9 was involved in the transcriptional regulation of annexin A2 (ANXA2). We demonstrated that HDAC9 was bound to the promoter region of ANXA2, leading to the downregulation of ANXA2 expression in high glucose-treated human retinal microvascular endothelial cells and STZ-induced DR model mice. Overexpression of ANXA2 significantly reduced the EndoMT process in STZ-induced DR model mice. Collectively, our results demonstrate that HDAC9 promotes EndoMT by regulating ANXA2 transcription, thereby disrupting vascular homeostasis during DR. This study sheds light on the roles of HDAC9 and ANXA2 in DR pathology and provides a theoretical foundation for the potential therapeutic strategies to target DR.
糖尿病视网膜病变(DR)是糖尿病常见且特有的微血管并发症,也是工作年龄成年人失明的主要原因。内皮-间充质转化(EndoMT)是各种慢性血管疾病的基础,而组蛋白去乙酰化酶9(HDAC9)参与心血管疾病、脑血管疾病、自身免疫性疾病和乳腺癌的病理过程。最近的证据表明,HDAC9促进EndoMT,从而影响动脉粥样硬化疾病的进展。在本研究中,我们研究了HDAC9在DR中的关键作用及其潜在机制。通过连续5天注射链脲佐菌素(STZ,50mg/kg)在小鼠中建立DR模型。定期监测血糖,并在建模后12周进行DR实验。我们发现,糖尿病患者玻璃体液和DR模型小鼠视网膜内皮细胞中HDAC9的表达水平显著升高。敲低内皮HDAC9可减少EndoMT并减轻体内DR病理,而HDAC9的过表达则加剧了DR模型小鼠的EndoMT。为了阐明HDAC9在DR中涉及的下游靶基因,我们对STZ诱导的视网膜病变中的视网膜进行了ChIP-seq和RNA-seq综合分析,并确定HDAC9参与膜联蛋白A2(ANXA2)的转录调控。我们证明HDAC9与ANXA2的启动子区域结合,导致高糖处理的人视网膜微血管内皮细胞和STZ诱导的DR模型小鼠中ANXA2表达下调。ANXA2的过表达显著减少了STZ诱导的DR模型小鼠中的EndoMT过程。总体而言,我们的结果表明,HDAC9通过调节ANXA2转录促进EndoMT,从而在DR期间破坏血管稳态。本研究揭示了HDAC9和ANXA2在DR病理中的作用,并为靶向DR的潜在治疗策略提供了理论基础。